Heart Disease
Medline Studies
Scientific Studies
Oral EDTA
Competitive Products
Toxic Metals
Main Technical Section For  Chelation Therapy On Line

 Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials		 Heart Disease & Bypass Surgery Home Page

Shopping Cart

Separate Search Page
or search below
Navigation Help

Karl Loren Background

 Ingredients
Technical		 Write To Karl Loren Table Of Contents

Kidney Disease Statistics

Illustration of kidney system Kidney and Urologic Diseases Statistics for the United States
Publications
Return to the NIDDK Home Page.

 


 

Kidney
Problems

 Kidney conditions (infection, kidney stones, cancer, missing kidney, other)

    Prevalence (1996): 2.553 million conditions (in the civilian noninstitutionalized population)1

 

Polycystic kidney disease

    Prevalence: About 600,000 people2

 

Hemolytic uremic syndrome, postdiarrheal

    Incidence (first 3 years of reporting)3

      1998: 90 cases in 17 States
      1997: 93 cases in 20 States
      1996: 104 cases in 18 States

 

End-stage renal disease (ESRD)

    Period prevalence (1998): 397,971 people4

      Resulting from these primary diseases:

        Diabetes: 132,747
        Hypertension: 82,560
        Glomerulonephritis: 66,826

     

    Incidence (new beneficiaries of treatment, 1998): 87,534 people4

      Resulting from these primary diseases:

        Diabetes: 34,874
        Hypertension: 18,273
        Glomerulonephritis: 9,493
        All other: 24,894

     

    ESRD deaths in treated patients (1998): 63,153 people4

    Amount spent (public and private, 1998): $16.74 billion4

    ESRD treatment:

      Use of dialysis (1998): 245,910 people4

        In-center hemodialysis: 208,579
        Home hemodialysis: 3,100
        Peritoneal dialysis: 25,273

          CAPD*: 15,371
          CCPD: 9,681
          Other PD: 221

        Uncertain dialysis: 8,958

        *CAPD=continuous ambulatory peritoneal dialysis; CCPD=continuous cycler-assisted peritoneal dialysis; PD=peritoneal dialysis


      Number of kidney transplants (by year, reported in annual facility survey)4:

        1998: 13,272
        1997: 12,427
        1988: 8,932


      Number of kidney transplants (by type, 1998, reported in annual facility survey)4:

        From cadaver: 8,752
        From living related donor: 3,453
        From living unrelated donor: 1,067


      People awaiting transplants (November 17, 2000)5:

        Kidney (only): 47,210
        Kidney and pancreas: 2,448


      Dialysis survival (probability of patients surviving, from day 91 of ESRD, unadjusted)4:

        1 year (1997-1998): 79.7
        2 years (1996-1998): 65.6
        5 years (1993-1998): 29.0
        10 years (1988-1998): 8.4


      Patient survival following cadaver transplant (probability of recipients surviving, from day 1 of transplantation, unadjusted)4:

        1 year (1997-1998): 94.4
        2 years (1996-1998): 91.8
        5 years (1993-1998): 79.5
        10 years (1988-1998): 56.5


      Patient survival following living-donor transplant (probability of recipients surviving, from day 1 of transplantation, unadjusted)4:

        1 year (1997-1998): 97.5
        2 years (1996-1998): 96.2
        5 years (1993-1998): 89.1
        10 years (1988-1998): 77.4


      Graft survival following cadaver transplant (probability of transplanted kidney surviving, from day 1 of transplantation, unadjusted)4:

        1 year (1997-1998): 87.7
        2 years (1996-1998): 79.7
        5 years (1993-1998): 58.4
        10 years (1988-1998): 32.2


      Graft survival following living-donor transplant (probability of transplanted kidney surviving, from day 1 of transplantation, unadjusted)4:

        1 year (1997-1998): 92.1
        2 years (1996-1998): 87.0
        5 years (1993-1998): 70.1
        10 years (1988-1998): 51.1


       

 

Urologic Problems

 Acute urinary conditions (infections of the kidneys and urinary tract, nephrotic syndrome, urethral stricture, cystitis, other)

    Incidence (1996): 8.405 million new conditions (in the civilian noninstitutionalized population)1

Bladder disorders

    Prevalence (1996): 3.139 million chronic conditions (in the civilian noninstitutionalized population)1

Interstitial cystitis

    Estimated prevalence: About 700,000 people (90 percent of whom are women)6

Kidney and ureter stones

    Doctor visits (1997): 1.325 million visits7
    Cost (total direct and indirect, 1993): $1.83 billion8
    Hospital discharges listing a diagnosis of urinary stones among all listed diagnoses (1998): 251,0009

Urinary tract infections (UTIs)

    Doctor visits (1997): 8.318 million visits7
    Hospital discharges listing a diagnosis of UTI among all listed diagnoses (1997): 1.637 million10
     

Urinary incontinence

    Prevalence: About 13 million adults11
    Societal cost (1995): $26.3 billion for individuals age 65 and older12

 

Other Related Problems

 Diseases of the prostate

    Prevalence (1996): 2.803 million men (in the noninstitutionalized population)1

Enlarged prostate (BPH)

    Prevalence: 50 percent of men age 51-60; 90 percent of men past age 8013
    Hospital discharges listing a diagnosis of BPH among all listed diagnoses (1997): 380,000 hospitalizations10

Erectile dysfunction (impotence)

    Incidence: 617,715 new cases (white men ages 40-69 only) annually14
    Estimated prevalence: 30 million men15

Prostate cancer

    Incidence (1995): 168,665 men develop it each year16
    Mortality (1995): 34,475 men die of it each year16

 

Sources
  1. Current Estimates From the National Health Interview Survey, 1996. Atlanta, GA: National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), U.S. Dept. of Health and Human Services (DHHS); October 1999. Vital and Health Statistics. Series 10, No. 200.
  2. Grantham JJ, Nair V, Winklhofer F. Cystic disease of the kidney. In: Brenner BM, ed., Brenner & Rector's The Kidney. Vol. 2. 6th ed. Philadelphia: WB Saunders Company; 2000: 1699-1730.
  3. Hemolytic uremic syndrome, postdiarrheal. Morbidity and Mortality Weekly Report. 1999;47(53):viii-ix.
  4. U.S. Renal Data System. USRDS 2000 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), DHHS; 2000. Available at www.usrds.org. Accessed August 18, 2000.
  5. United Network for Organ Sharing. Available at www.unos.org. Accessed November 27, 2000. For updates, call (804) 330-8576 or fax (804) 323-3794.
  6. Ratner V, Taylor N, Wein AJ, Hanno PJ. Re: Epidemiology of interstitial cystitis: a population based study. Journal of Urology. 1999;162(2):500. Letter.
  7. Ambulatory Care Visits to Physician Offices, Hospital Outpatient Departments, and Emergency Departments: United States, 1997. Atlanta, GA: NCHS, CDC, DHHS; November 1999. Vital and Health Statistics. Series 13, No. 143.
  8. Clark JY, Thompson IM, Optenberg SA. Economic impact of urolithiasis in the United States. Journal of Urology. 1995;154(6):2020-2024.
  9. National Hospital Discharge Survey: Annual Summary, 1998. Atlanta, GA: NCHS, CDC, DHHS; September 2000. Vital and Health Statistics. Series 13, No. 148.
  10. Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1997. Atlanta, GA: NCHS, CDC, DHHS; December 1999. Vital and Health Statistics. Series 13, No. 145.
  11. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline No. 2, 1996 Update. Rockville, MD: Agency for Health Care Policy and Research (AHCPR), DHHS; March 1996. AHCPR publication 96-0682.
  12. Wagner TH, Hu TW. Economic costs of urinary incontinence in 1995. Urology. 1998;51(3):355-361.
  13. McConnell JD. Epidemiology, etiology, pathophysiology, and diagnosis of benign prostatic hyperplasia. In: Walsh PC, et al., eds., Campbell's Urology. Vol. 2. 7th ed. Philadelphia: WB Saunders Company; 1998: 1429-1452.
  14. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. Journal of Urology. 2000; 163(2):460-463.
  15. Impotence: National Institutes of Health Consensus Development Conference Statement. NIH, DHHS. December 7-9, 1992; 10(4):1-31. Available at odp.od.nih.gov/consensus/cons/091/091_statement.htm. Accessed August 21, 2000.
  16. Stanford JL, Stephenson RA, Colye LM, et al. Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute, NIH, DHHS. Available at www.seer.cancer.gov/Publications/ProstMono. Accessed August 21, 2000. Last updated September 7, 1999.

 
 
 

National Kidney and Urologic Diseases Information Clearinghouse

3 Information Way
Bethesda, MD 20892-3580
Email: nkudic@info.niddk.nih.gov

The National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK is part of the National Institutes of Health under the U.S. Department of Health and Human Services. Established in 1987, the clearinghouse provides information about diseases of the kidneys and urologic system to people with kidney and urologic disorders and to their families, health care professionals, and the public. NKUDIC answers inquiries; develops and distributes publications; and works closely with professional and patient organizations and Government agencies to coordinate resources about kidney and urologic diseases.

Publications produced by the clearinghouse are carefully reviewed by both NIDDK scientists and outside experts.

This e-text is not copyrighted. The clearinghouse encourages users of this e-pub to duplicate and distribute as many copies as desired.


 
Publications
Return to the NIDDK Home Page.

 



 

 NIH Publication No. 01-3895
June 1999

Updated: February 2001

 

 

If you missed it, you can go to either a SHORT explanation of the whole story, or a detailed explanation on ONE PAGE.  On this page you are getting more detail on one part of the story, but on either of those pages you can get the broad picture.  Don't miss reading one of them.  You can actually spend many hours on this web site, depending on the depth of research and reading you want to do.  There are an amazing 4,000 pages here -- more information on these general subjects than almost all other web sites combined!  At some point along the way you will probably say, "Karl's crazy," and leave never to return to this site, or you will say "I want to try some of that oral chelation formula he writes about!"

 

 
Special Pages On The Various of 12 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List		 American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List		 FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        
 

 

 

  

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY. 

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.